Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
AIDS (London, England)|January 31, 2003
Effects of interleukin-2 therapy combined with highly active antiretroviral therapy on immune restoration in HIV-1 infection: a randomized controlled trialYves Levy, Christine Durier, Roman Krzysiek, et al.
The Journal of Infectious Diseases|June 2, 2011
Safety and immunogenicity of a monovalent 2009 influenza A/H1N1v vaccine adjuvanted with AS03A or unadjuvanted in HIV-infected adults: a randomized, controlled trialOdile Launay, Corinne Desaint, Christine Durier, et al.
The Journal of Infectious Diseases|July 16, 2025
Characteristics of Human Metapneumovirus Infection Compared to Respiratory Syncytial Virus and Influenza Infections in Adults Hospitalized for Influenza-Like Illness in France, 2012-2022Paul Loubet, Salomé Guitton, Simon Rolland, et al.
Plos One|August 23, 2007
Cellular immune responses induced with dose-sparing intradermal administration of HIV vaccine to HIV-uninfected volunteers in the ANRS VAC16 trialOdile Launay, Christine Durier, Corinne Desaint, et al.
The Lancet. Infectious Diseases|June 1, 2022
Immunoglobulin-free strategy to prevent HBV mother-to-child transmission in Cambodia (TA-PROHM): a single-arm, multicentre, phase 4 trialOlivier Segeral, Bunnet Dim, Christine Durier, et al.
Ebiomedicine|January 19, 2022
Safety and immunogenicity of a measles-vectored SARS-CoV-2 vaccine candidate, V591 / TMV-083, in healthy adults: results of a randomized, placebo-controlled Phase I studyOdile Launay, Cécile Artaud, Marie Lachâtre, et al.
Infectious Diseases Now|March 17, 2024
Incidence of COVID-19 mRNA vaccine symptomatic breakthrough infections during Omicron circulation in adults with or without infection prior to vaccinationChristine Durier, Laetitia Ninove, Sylvie van der Werf, et al.
Iscience|August 6, 2024
Cytokine profile of anti-spike CD4<sup>+</sup>T cells predicts humoral and CD8<sup>+</sup>T cell responses after anti-SARS-CoV-2 mRNA vaccinationNadine Benhamouda, Anissa Besbes, Rebecca Bauer, et al.
Scientific Reports|November 27, 2022
Neutralizing antibodies against SARS-CoV-2 variants following mRNA booster vaccination in adults older than 65 yearsChristine Durier, Laetitia Ninove, Maeva Lefebvre, et al.
JAMA Network Open|April 23, 2024
Serum and Salivary IgG and IgA Response After COVID-19 Messenger RNA VaccinationGuy Gorochov, Jacques Ropers, Odile Launay, et al.
Pageof 4